Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2665)	1/13/2010 2:21:20 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

HTRN is up 8.71% and volume of 122,198 is about 2x its ADV.<g> The stock hasn't closed the UG of Jan7 and wants to continue its up-move. <g> bigcharts.marketwatch.com HTRN has 4Qs of better revenues and earnings were also better (by 25%) in the 3rdQ, but the 4thQ results aren't expected to be good. That is if the EE by the "analysts" are correct, since earning for the Yr. are projected at $0.08 vs. the $0.10 in 2008. However, for 2010 they expect an improvement of 117% <g> HTRN has a good size LTD, but it also has good +CF. In July it acquired Endocare. It seems that with some good news, after it reports its DecQ, the stock could get to test the resistance at the $5 level. The ACTAY is $5.25 <g> bigcharts.marketwatch.com Bernard